LEVOLEUCOVORIN

Generic: LEVOLEUCOVORIN

Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAVENOUSRoute
LEVOLEUCOVORIN CALCIUMActive Substance
2016-06-16Original Approval

LEVOLEUCOVORIN is FDA application ANDA206263, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
NAUSEA
303 reports
2
OFF LABEL USE
280 reports
3
NEUTROPENIA
259 reports
4
DIARRHOEA
254 reports
5
DECREASED APPETITE
191 reports
6
VOMITING
179 reports
7
MALIGNANT NEOPLASM PROGRESSION
169 reports
8
NEUROPATHY PERIPHERAL
159 reports
9
PYREXIA
144 reports
10
ASTHENIA
141 reports